How many institutions held ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in Q2 2023?

32 institutional investors reported ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value for Q2 2023. Use the holders table for investor-level position and value details.

Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)

Q: What does CUSIP 28617K101 represent in this 13F holders report?

CUSIP 28617K101 is the security identifier for ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value used to aggregate holder disclosures.

CUSIP: 28617K101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.001 par value
Shares outstanding: 78,762,953
Total 13F shares: 9,275,200
Share change: +3,034,539
Total reported value: $12,707,758
Price per share: $1.37
Number of holders: 32
Value change: +$2,932,975
Number of buys: 15
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 28617K101?
CUSIP 28617K101 identifies ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 28617K101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BVF INC/IL	13F	Company	3%	2,326,710	$5,491,036	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	1.5%	1,217,882	$2,874,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.86%	679,557	$1,603,754	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.66%	516,675	$1,219,353	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.56%	443,001	$1,045,482	—	31 Mar 2023	13F
Gary A. Lyons	3/4/5	Director	— class O/S missing	150,437	$673,958	—	01 May 2023	3/4/5
CM Management, LLC	13F	Company	0.3%	234,800	$554,000	—	31 Mar 2023	13F
Ikarian Capital, LLC	13F	Company	0.28%	221,830	$523,518	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	129,151	$304,796	—	31 Mar 2023	13F
JMAC ENTERPRISES LLC	13F	Company	0.07%	54,538	$128,710	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.07%	52,568	$124,060	—	31 Mar 2023	13F
INGALLS & SNYDER LLC	13F	Company	0.06%	50,849	$120,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.06%	44,692	$105,473	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.04%	32,173	$76,000	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	30,810	$72,712	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.04%	30,053	$70,925	—	31 Mar 2023	13F
SVB FINANCIAL GROUP	13F	Company	0.03%	26,942	$63,583	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	25,100	$59,236	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.03%	22,050	$52,038	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	17,954	$42,371	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.02%	17,586	$41,503	—	31 Mar 2023	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	0.02%	16,726	$39,000	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	14,987	$35,369	—	31 Mar 2023	13F
Veritable, L.P.	13F	Company	0.02%	13,029	$30,748	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	12,605	$30,000	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	6,251	$15,000	—	31 Mar 2023	13F
Ameritas Advisory Services, LLC	13F	Company	0%	1,000	$2,270	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0%	600	$1,416	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0%	456	$1,076	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	86	$203	—	31 Mar 2023	13F
Walter C. Ogier	3/4/5	Director	— class O/S missing	150,437	—	—	01 May 2023	3/4/5

Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q2 2023

As of 30 Jun 2023, Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,275,200 shares. The largest 10 holders included BVF INC/IL, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Woodline Partners LP, Ensign Peak Advisors, Inc, Royal Bank of Canada, CM Management, LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, and JMAC ENTERPRISES LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.